Takagi Kensuke, Fujino Yusuke, Naganuma Toru, Watanabe Yusuke, Yabushita Hiroto, Mitomo Satoru, Kawamoto Hiroyoshi, Tahara Satoko, Kobayashi Tsuyoshi, Warisawa Takayuki, Karube Kenichi, Matsumoto Takahiro, Sato Tomohiko, Ishiguro Hisaaki, Kurita Naoyuki, Nakamura Shotaro, Hozawa Koji, Nakamura Sunao
Department of Cardiology, New Tokyo Hospital; Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.
Department of Cardiology, New Tokyo Hospital; Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan.
Cardiovasc Revasc Med. 2016 Dec;17(8):515-521. doi: 10.1016/j.carrev.2016.08.012. Epub 2016 Sep 4.
There is no consensual opinion regarding the percutaneous coronary intervention (PCI) procedure for unprotected distal left main (UDLM) lesion.
Between April 2005 and August 2011, 586 consecutive patients with UDLM stenosis treated with drug-eluting stents were recruited for this study to clarify the impact of combination of full-coverage stenting and proximal optimization technique (POT) for UDLM lesion. An optimal strategy of full-coverage stenting and POT was performed in 353 patients and the other 233 patients were not optimally treated. Major adverse cardiovascular events (MACEs) were defined as all-cause death, myocardial infarction, or target lesion revascularization (TLR) during follow-up period. TLRs were also evaluated for main branch (MB) restenosis.
At 1615days of follow-up, MACE occurred in 166 (28.3%) patients. The occurrence of MACE and TLR had a trend to being lower in the optimal strategy [propensity score-adjusted HR, 0.73 (95% CI, 0.53-1.01), p=0.05 and propensity score-adjusted HR, 0.69 (95% CI, 0.46-1.02), p=0.06, respectively]. TLR of the MB occurred significantly less frequently in the optimal strategy [propensity score-adjusted HR, 0.34 (95% CI, 0.15-0.76), p=0.008]. Cardiac death occurred in 28 (4.8%) patients. There was no significant difference in cardiac death between the two groups. These results were sustained after propensity-score matching.
An optimal PCI strategy of full-coverage stenting and POT might be effective for UDLM lesion to reduce the occurrence of MACE, especially driven by TLR of the MB.
对于无保护左主干远端(UDLM)病变的经皮冠状动脉介入治疗(PCI),目前尚无共识。
2005年4月至2011年8月,连续纳入586例接受药物洗脱支架治疗的UDLM狭窄患者,以明确全覆盖支架置入联合近端优化技术(POT)对UDLM病变的影响。353例患者采用全覆盖支架置入和POT的优化策略,另外233例患者未接受优化治疗。主要不良心血管事件(MACE)定义为随访期间的全因死亡、心肌梗死或靶病变血运重建(TLR)。还对主要分支(MB)再狭窄的TLR进行了评估。
随访1615天时,166例(28.3%)患者发生MACE。优化策略组MACE和TLR的发生率有降低趋势[倾向评分调整后的HR分别为0.73(95%CI,0.53 - 1.01),p = 0.05和倾向评分调整后的HR为0.69(95%CI,0.46 - 1.02),p = 0.06]。优化策略组MB的TLR发生率显著降低[倾向评分调整后的HR为0.34(95%CI,0.15 - 0.76),p = 0.008]。28例(4.8%)患者发生心源性死亡。两组在心源性死亡方面无显著差异。倾向评分匹配后这些结果依然成立。
全覆盖支架置入和POT的优化PCI策略可能对UDLM病变有效,可减少MACE的发生,尤其是由MB的TLR所致的MACE。